Can’t find a document? Request Information

CH-Q0007 : Copptech: A Antiviral Biotech

Project Status: Implementation

The project's goal is to provide Covid-19 crisis response financing for sustaining andpromoting Copptech's expansion to improve households and business resilience against Covid-19. Copptech develops and manufactures chemicals based on zinc and copper that neutralize the effect of the Cov-SARS-2 virus in different types of surfaces, such as wood polymers and metals. Its requesting a loan from LIFESS to comply with a drastic increase in demand for its products.

Project Detail

Project Number

CH-Q0007

Approval date

January 10, 2023

Project Country

Chile

Project Sector

PRIVATE FIRMS AND SME DEVELOPMENT

Project Subsector

ENTERPRISE DEVELOPMENT, CLUSTERS AND INNOVATION

Project Type

Equity

Project Lending Type

NSG

Project Modality

Project Facility Type

Project Status

Implementation

Operation Number

EQU/MS-19858-CH

Financial Information

Project Number

CH-Q0007

Project Status

Implementation

IDB Financing

Financing type

EQU

Fund

MIF-Small Enterprise Investment Fund

Reporting currency

USD - United States Dollar

Reporting date

Jun/05/2023

Roles & Responsibilities

Contract signature date

Jan/10/2023

Project Information

Total Cost

USD 1

Country counterpart financing

USD 0

Amount